Calsporin (Bacillus velezensis DSM 15544) Calsporin (Bacillus velezensis DSM 15544)

Is Calsporin healthy for dogs?

Calsporin is a research-backed, spore-forming probiotic strain with a well-established safety and efficacy profile in companion animal nutrition — providing Bacillus velezensis DSM 15544, a strain that supports gut microbiome balance, helps modulate the immune response at the gut level, and contributes to a healthy digestive environment through its capacity to survive the gastrointestinal tract in spore form.

Calsporin is the commercial name for Bacillus velezensis DSM 15544 — previously classified as Bacillus subtilis C-3102, though taxonomic reclassification has confirmed its status as Bacillus velezensis. It is one of the few probiotic strains to have achieved regulatory approval as a gut flora stabiliser in pet food under EU feed additive legislation (4b1820), reflecting its established safety and documented efficacy.

A regulatory-approved Bacillus spore-forming probiotic that supports gut flora balance, helps inhibit pathogenic bacteria through bacteriocin production and competitive exclusion, modulates gut-associated immune function, and provides the manufacturing and storage stability advantages of spore-forming bacteria.

As a spore-former, Bacillus velezensis DSM 15544 can survive the heat, pressure, and acid conditions of the manufacturing process and the acidic environment of the stomach, ensuring viable cells reach the small intestine and colon where they exert their biological effects.

Calsporin produces bacteriocins and antimicrobial lipopeptides that inhibit the growth of pathogenic bacteria including Clostridium perfringens, Salmonella, and E. coli, supporting a more balanced and protective gut microbial environment.

The strain has documented immunomodulatory effects at the gut level, including interaction with gut-associated lymphoid tissue (GALT) and support for secretory IgA production, contributing to mucosal immune defence.

Calsporin is included at a substantial CFU count (166,670,872 CFU/g in the formulation), reflecting the dosing levels at which its biological effects have been characterised in research and regulatory submissions.

Science Informed Reasons to Include This Ingredient in Your Dog’s Diet:

1. Spore-Forming Stability — the spore form of Bacillus velezensis DSM 15544 survives manufacturing heat, acid conditions in the stomach, and bile salt exposure in the small intestine, ensuring viable cells reach the colon where probiotic effects are exerted.
2. Pathogen Inhibition — Calsporin produces bacteriocins and antimicrobial lipopeptides that inhibit the growth of pathogenic bacteria including Clostridium perfringens, Salmonella, and certain E. coli strains, supporting a more balanced and protective gut environment.
3. Competitive Exclusion — by establishing itself in the gut environment, Calsporin competes with pathogenic bacteria for adhesion sites and nutrients, contributing to the maintenance of a healthy microbial balance through competitive exclusion.
4. Gut-Associated Immune Modulation — Calsporin interacts with GALT and supports secretory IgA production, contributing to mucosal immune defence and helping maintain the immune homeostasis of the gut epithelium.
5. Microbiome Diversity Support — research indicates Bacillus velezensis DSM 15544 supports a more diverse gut microbial community, contributing to the resilience and stability of the gut microbiome, particularly during dietary transitions or immune challenges.
6. EU Regulatory Approval — Calsporin holds authorisation as a zootechnical feed additive (gut flora stabiliser) for dogs under EU feed legislation, providing regulatory validation of its safety and the evidence base for its function as a probiotic in companion animal nutrition.
7. Complementary to Lactobacillus helveticus — within the Boost formulation, Calsporin provides the stability and spore-forming resilience of a Bacillus-family probiotic, while L. helveticus HA-122 provides the Lactobacillus-family effects. These two strains support gut health through distinct, complementary mechanisms.
8. Canine-Specific Evidence — Calsporin’s regulatory dossier and supporting research includes data from companion animal feeding trials, providing a species-relevant evidence base that goes beyond extrapolation from human or agricultural animal research.